DALRADA FINCL CORP - DFCO STOCK NEWS

Dalrada Financial (OTCQB: DFCO) has been invited to join the Minority Business RoundTable (MBRT), a prestigious nonprofit organization led by Roger Campos. This membership allows Dalrada unique access to business opportunities in public, private, and government sectors, enhancing its influence and reach globally. Dalrada’s gold-level sponsorship underscores its commitment to a lasting partnership with MBRT. CEO Brian Bonar highlighted the potential for increased awareness and credibility among policymakers, while Campos praised Dalrada's innovative contributions to local and global economies. This strategic move aligns with Dalrada's mission to effect positive change through its technological solutions in climate and healthcare.

Dalrada Financial (OTCQB: DFCO) announced that its healthcare subsidiary, Genefic, has acquired IV Services, , a leading pharmaceutical and infusion management company. This acquisition strengthens Genefic’s market position by expanding its sales and operational footprint, increasing top-line revenue, and enhancing patient care capabilities. The acquisition is non-dilutive to shareholders and allows Genefic to enter the $42 billion global infusion pharmacy management market, which is expected to grow to $70 billion by 2030. Genefic gains new regional presence in Louisiana and Mississippi, complementing its existing operations in several other U.S. states.

Dalrada Financial (OTCQB: DFCO) filed a Form 10-Q for Q3 2024, revealing a revenue of $10.3 million, driven primarily by its pharmaceutical subsidiary, Genefic Specialty Pharmacy. Genefic accounted for $8.6 million, an 80% increase from Q3 2023 and a 95.5% rise from the previous quarter. The company also converted $13.3 million of affiliate debt to Series I preferred shares, reducing net losses to $2.9 million, the lowest since 2021. CEO Brian Bonar emphasized ongoing efforts to clear debt and reduce expenditures, with a net equity of $8.8 million. Dalrada anticipates continued growth in Q4 and a year-over-year revenue increase by the end of fiscal 2024.

Dalrada Financial 's subsidiary, Genefic, Inc., introduces new telemedicine services to tap into the booming weight loss drug market. With a projected market value of nearly $100 billion by the end of the decade, Genefic aims to leverage its telemedicine service to offer clients direct access to its weight loss drug, capitalizing on the increasing popularity of such pharmaceuticals. The subsidiary's partnership with a renowned weight loss provider and the endorsement of celebrities like Oprah Winfrey and Elon Musk further solidify its market position.

Dalrada Financial (DFCO) files provisional patent application for unique carbon utility tokens system, positioning itself in the $100 billion carbon credit market.

Dalrada Financial forms Dalrada Home Corp. Advisory Board to focus on the booming home heat pump market, with experienced board members from energy technology and renewable energy sectors. The U.S. domestic market is valued at over $13 billion and expected to reach $30 billion in less than 10 years.

Dalrada Financial (DFCO) enters the carbon credit market with a powerful software system and hardware device, poised to capture a significant market share. The company's innovative solution simplifies carbon credit generation and trading, targeting various industries and global markets.

Dalrada Financial (DFCO) launches Dalrada Home Inc., a subsidiary entering the booming U.S. home heat pump market expected to reach $30 billion by 2032. The company aims to provide high-efficiency, cost-saving heat pumps for residential use, targeting American single-family homes. Dalrada plans to announce its product lineup in three to four weeks, with priority shipping available in approximately four weeks. The move aligns with global decarbonization efforts, offering eco-friendly solutions to reduce energy costs and carbon footprints.

Dalrada Financial Corporation (DFCO) reduces authorized shares by 50% to 500 million, aiming to clean up capitalization for future growth. CEO Brian Bonar emphasizes the strategic move to enhance shareholder value.